246 related articles for article (PubMed ID: 1299717)
21. WHO global strategy for further reducing the leprosy burden and sustaining leprosy control activities (Plan period: 2006-2010).
World Health Organization
Indian J Lepr; 2006; 78(1):7-31. PubMed ID: 16646281
[No Abstract] [Full Text] [Related]
22. WHO regional strategy for sustaining leprosy services and further reducing the burden of leprosy, 2006-2010.
WHO Regional Office for South-East Asia
Indian J Lepr; 2006; 78(1):33-47. PubMed ID: 16646282
[No Abstract] [Full Text] [Related]
23. Leprosy elimination--urgent action required.
Sansarricq H
Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):60-3. PubMed ID: 10407630
[No Abstract] [Full Text] [Related]
24. Personalised therapy vs. fixed duration therapy.
Salafia A
Lepr Rev; 1997 Dec; 68(4):375-8. PubMed ID: 9503875
[No Abstract] [Full Text] [Related]
25. Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions.
Legendre DP; Muzny CA; Swiatlo E
Pharmacotherapy; 2012 Jan; 32(1):27-37. PubMed ID: 22392826
[TBL] [Abstract][Full Text] [Related]
26. Hansen's disease (leprosy).
Wariyar B
Nebr Med J; 1996 May; 81(5):147-8. PubMed ID: 8975147
[No Abstract] [Full Text] [Related]
27. Co-localization of Pityriasis versicolor and BT Hansen's disease.
Narang T; Dogra S; Kaur I
Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):206-7. PubMed ID: 16830643
[No Abstract] [Full Text] [Related]
28. Relapse after long-term follow up of multibacillary patients treated by WHO multidrug regimen.
Jamet P; Ji B
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):622. PubMed ID: 7868967
[No Abstract] [Full Text] [Related]
29. Leprosy elimination in India--so near.
Rao CK
Indian J Lepr; 2005; 77(3):207-11. PubMed ID: 16353518
[No Abstract] [Full Text] [Related]
30. Future trends in the treatment of leprosy.
Pattyn SR
Trop Geogr Med; 1994; 46(2):85-8. PubMed ID: 8079396
[No Abstract] [Full Text] [Related]
31. Priorities for the future and prospects for leprosy control.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):82-101. PubMed ID: 8326185
[No Abstract] [Full Text] [Related]
32. Neurological manifestations of Hansen's disease and their management.
Agrawal A; Pandit L; Dalal M; Shetty JP
Clin Neurol Neurosurg; 2005 Oct; 107(6):445-54. PubMed ID: 16202816
[TBL] [Abstract][Full Text] [Related]
33. Short term WHO advised multiple drug treatment of paucibacillary patients.
Naafs B; Lyons NF; Matemera BO; Ellis BP
Indian J Lepr; 1986; 58(2):348-53. PubMed ID: 3805802
[No Abstract] [Full Text] [Related]
34. Acute renal failure and multidrug therapy for leprosy.
Nishioka Sde A
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):259-60. PubMed ID: 9251601
[No Abstract] [Full Text] [Related]
35. Leprosy control through multidrug therapy (MDT).
Noordeen SK
Bull World Health Organ; 1991; 69(3):263-9. PubMed ID: 1893503
[TBL] [Abstract][Full Text] [Related]
36. Success of the WHO multidrug therapy?
Becx-Bleumink M
Trop Geogr Med; 1994; 46(2):61-4. PubMed ID: 8079392
[No Abstract] [Full Text] [Related]
37. Multidrug therapy in leprosy.
Manglani PR; Arif MA
J Indian Med Assoc; 2006 Dec; 104(12):686-8. PubMed ID: 17474286
[TBL] [Abstract][Full Text] [Related]
38. Eliminating leprosy as a public health problem; why the optimism is justified.
Noordeen SK
Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):559-66. PubMed ID: 8642220
[No Abstract] [Full Text] [Related]
39. New perspectives for the treatment of Hansen's disease.
Talhari S; Gontijo B; Vale ECSD; Marques SA
An Bras Dermatol; 2017; 92(6):760. PubMed ID: 29364429
[No Abstract] [Full Text] [Related]
40. Hansen's disease (leprosy) revisited.
Wariyar B; Adams LM
Nebr Med J; 1986 Oct; 71(10):357-8. PubMed ID: 3774061
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
